Skip to main content

Discovering novel antibodies derived from the human body itself to treat neurodegenerative diseases

Project description

An eagle's eye for antibodies associated with rare diseases may revolutionise therapy

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /medical and health sciences/basic medicine/immunology

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

MABYLON AG
Address
Wagistrasse 14
8952 Schlieren
Switzerland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000